本页面由Tiger Trade Technology Pte. Ltd.提供服务

Oric Pharmaceuticals Inc.

14.20
+0.32002.31%
成交量:97.05万
成交额:1,367.85万
市值:14.70亿
市盈率:-10.51
高:14.34
开:14.00
低:13.81
收:13.88
52周最高:14.93
52周最低:7.23
股本:1.04亿
流通股本:8,868.67万
量比:0.88
换手率:1.09%
股息:- -
股息率:- -
每股收益(TTM):-1.3513
每股收益(LYR):-1.4747
净资产收益率:-39.80%
总资产收益率:-25.97%
市净率:3.86
市盈率(LYR):-9.63

数据加载中...

2026/08/04

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/04

重要事件披露

Form 8-K - Current report
2026/07/30

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/07/30

重要事件披露

Form 8-K - Current report
2026/07/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/23

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/12

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/04

重要事件披露

Form 8-K - Current report
2026/04/01

重要事件披露

Form 8-K - Current report
2026/02/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/24

重要事件披露

Form 8-K - Current report
2026/02/23

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/23

重要事件披露

Form 8-K - Current report
2026/02/23

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]